Government Pension Fund Global (Norway) decreased its stake in Dr. Reddy's Laboratories Limited from 1.10% to 1.08%, selling 125,428 shares.
A leading India-based pharmaceutical company, Dr Reddy's Laboratories manufactures and distributes Active Pharmaceutical Ingredients, generic medicines, biosimilars, and differentiated formulations across multiple therapeutic areas. The company operates custom pharmaceutical services and serves patients in markets worldwide. Its integrated operations span drug discovery, development, manufacturing, and commercialization of innovative and generic pharmaceuticals for diverse healthcare needs.
Norway's sovereign wealth fund, managed by Norges Bank Investment Management. World's largest SWF with over USD 2 trillion in assets, invested across 8,700+ companies globally including Indian equities.
